LEXARIA BIOSCIENCE CORP. Liabilities of Assets Held-for-sale (Deprecated 2014-01-31)
LEXARIA BIOSCIENCE CORP. (LEXX) had Liabilities of Assets Held-for-sale (Deprecated 2014-01-31) of $678.19 thousand as of 2014-11-30, per its 10-Q filed 2015-01-14.
Discontinued › Notes
us-gaap:LiabilitiesOfAssetsHeldForSale · last filed 2015-01-14
- 2014-11-30: Liabilities of Assets Held-for-sale (Deprecated 2014-01-31) $678.19K.
- 2014-08-31: Liabilities of Assets Held-for-sale (Deprecated 2014-01-31) $0.00.
- 2013-10-31: Liabilities of Assets Held-for-sale (Deprecated 2014-01-31) $59.24K.
| Period end | Liabilities of Assets Held-for-sale (Deprecated 2014-01-31) |
|---|---|
| 2014-11-30 | $678.19K 10-Q · filed 2015-01-14 |
| 2014-08-31 | $0.00 10-Q · filed 2015-01-14 |
| 2013-10-31 | $59.24K 10-KT · filed 2014-12-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |